Effect of eicosapentaenoic acid intake on the relationship between interleukin-6 and acute phase proteins in serum in youths

Environmental Health and Preventive Medicine

Volumn 2, Issue 2, 1997, Pages 70-73

  Sakamoto, Naomasa ^a   Wakabayashi, Ichiro ^a   Yoshimoto, Sachiko ^a   Masui, Hidehisa ^a   Sakamoto, Kunihiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Acute phase protein; Eicosapentaenoic acid; Interleukin 6; Physical exercise; Total cholesterol

Indexed keywords

ACUTE PHASE PROTEIN; ICOSAPENTAENOIC ACID; INTERLEUKIN 6;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG EFFECT; ERYTHROCYTE MEMBRANE; EXERCISE; FIBRINOLYSIS; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN;

EID: 0030678596     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931967     Document Type: Article

References (22)

1. Cauldie J, Richards C, Northmann W, Feg G, Baumann H. IFN β2/ β SF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann NY Acad SCi 1989; 557: 46-59.
2. Curb JD, Reed DM. (Letter). N Engl J Med 1985; 313: 821-2.
3. Gauldie J, Richards C, Harnish D, Landsdorp P, Baumann H. Interferon 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251-5.
4. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39-48.
5. Matsuda T, Hirano T. Interleukin-6 (IL-6/BSF-2). Nipponrinsho 1990; 48: 292-7.
6. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993; 26: 1299-304.
7. Ohzato H, Monden M, Yoshizaki K, Ogata A, Nishimoto N, Gotoh M, Kishimoto T. Systemic production of interleukin-6 following acute inflammation. Biochem Biophys Res Commun 1993; 197: No 3, 1556-62.
8. Yamagishi Y, Hidaka Y, Sasaki K, Nihei K, Itoh Y, Kawai T. Determination of serum interleukin-6 concentration by an enzymelinked immunosorbent assay in patients with paraproteinemia. Rinshobyori 1992; 40: 3, 303-10.
9. Smith JA, Telford RD, Baker MS, Hapel AJ, Weidemann MJ. Cytokine immunoreactivity in plasma does not change after moderate endurance exercise. J Appl Physiol 1992; 73: 1396-401.
10. Tamura Y, Hirai A, Terano T, Saito H. Benefit from the ocean, clinical efficacy of ω-3 polyunsaturated fatty acids. Gendai Iryo 1992; 24: 755-86.
11. Meydani SM, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Pinarello CA, Gorback SL. Effect of oral n-3 fatty acid supplementation on the immune response of young and older womwn. Adv Prostaglandin Thromboxane. Leukot Res 1990; 21: 245-8.
12. Sakurabayashi I, Kawai T. Principles and applications of immunoassay: Nephelometry related analysis. Jpn J Clin Pathol 1983; suppl 53: 71-81.
13. Ozawa A, Takayanagi K, Fujita T, Hirai A, Hamazaki T, Terano T, Tamura Y, Kumagai A. Determination of long chain fatty acids in human total plasma lipids using gas chromatography. Bunseki Kagaku 1982; 31: 87-91.
14. Yachie A, Ota K, Ueno Y, Oki T, Hoshiba T, Yabuki Y, Miyawaki T, Taniguchi N. Measurement of blood IL-6 levels in children-A sensitive indicator of acute inflammation-. J Jpn Pediatr Soc 1992; 96 (1): 110-4.
15. Migita S. Acute phase protein and inflammation. J Med Technol 1988; 32: 160-6.
16. Thompson D, Milford-Ward A, Whicher JT. The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 1992; 29: 123-31.
17. Terano Y. Haptoglobin (Hp). Jpn J Clin Med 1989; 47: 141-7.
18. Haq S, Tun P, Haq M, Crook M. Serum sialic acid and acute-phase proteins in hypertriglyceridaemic patients showing the Frederickson's type 11B phenotype. Clin Sci 1993; 85: 219-22.
19. Kosaka A, Matsumoto H, Ohori M. Evaluation of correlation between serum sialic acid and various serum specific proteins. Jpn J Clin Pathol 1988; 36: 679-84.
20. Orekhov AN, Tertor W, Mukhin DN, Mikhailenko IA. Desialylated low density lipoprotein-naturally occurring modified liporotein with atherogenic potency. Atherosclerosis 1991; 86: 153-61.
21. Lindberg G, Eklund GA, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. Br Med J 1991; 302: 143-6.
22. Wakabayashi K, Sakamoto K, Yoshimoto S, Masui H. Relation of serum sialic acid to lipid concentration. Br Med J 1992; 305: 562-3.